A BENZYL ALCOHOL, U.S.P./N.F. CEP of the European Pharmacopoeia monograph is often referred to as a BENZYL ALCOHOL, U.S.P./N.F. Certificate of Suitability (COS). The purpose of a BENZYL ALCOHOL, U.S.P./N.F. CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of BENZYL ALCOHOL, U.S.P./N.F. EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of BENZYL ALCOHOL, U.S.P./N.F. to their clients by showing that a BENZYL ALCOHOL, U.S.P./N.F. CEP has been issued for it. The manufacturer submits a BENZYL ALCOHOL, U.S.P./N.F. CEP (COS) as part of the market authorization procedure, and it takes on the role of a BENZYL ALCOHOL, U.S.P./N.F. CEP holder for the record. Additionally, the data presented in the BENZYL ALCOHOL, U.S.P./N.F. CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the BENZYL ALCOHOL, U.S.P./N.F. DMF.
A BENZYL ALCOHOL, U.S.P./N.F. CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. BENZYL ALCOHOL, U.S.P./N.F. CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of BENZYL ALCOHOL, U.S.P./N.F. suppliers with CEP (COS) on PharmaCompass.